UR N-C Urinary Antiseptic (Mayne Pharma Inc.)
Welcome to the PulseAid listing for the UR N-C Urinary Antiseptic drug offered from Mayne Pharma Inc.. This Oxidation-Reduction Agent [EPC],Oxidation-Reduction Activity [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Mayne Pharma Inc. |
| NON-PROPRIETARY NAME: | Hyoscyamine Sulfate, Methenamine, Phenyl Salicylate, Sodium Phosphate Monobasic, Methylene Blue |
| SUBSTANCE NAME: | HYOSCYAMINE SULFATE; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE; PHENYL SALICYLATE; METHENAMINE; METHYLENE BLUE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Oxidation-Reduction Agent [EPC],Oxidation-Reduction Activity [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET |
| MARKETING CATEGORY NAME: | UNAPPROVED DRUG OTHER |
| START MARKETING DATE: | 2011-05-21 |
| END MARKETING DATE: | 2018-04-30 |
UR N-C Urinary Antiseptic HUMAN PRESCRIPTION DRUG Details:
| Item Description | UR N-C Urinary Antiseptic from Mayne Pharma Inc. |
| LABELER NAME: | Mayne Pharma Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | .12; 40.8; 36.2; 81.6; 10.8(mg/1; mg/1; mg/1; mg/1; mg/1) |
| START MARKETING DATE: | 2011-05-21 |
| END MARKETING DATE: | 2018-04-30 |
| PRODUCT ID: | 51862-175_66612c80-f251-449a-98c2-eb7b67a7af42 |
| PRODUCT NDC: | 51862-175 |
| APPLICATION NUMBER: | |
Other HYOSCYAMINE SULFATE; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE; PHENYL SALICYLATE; METHENAMINE; METHYLENE BLUE Pharmaceutical Manufacturers / Labelers:
